Does Omitron have in Kosovo: Our country still sends tests to Germany when its results are expected

Kosovo expects by the end of December to accept the result of samples sent abroad, to see if they are positive for the new version of the coronary, Omitron. “And we have not accepted the results of the latest samples. The exact date is not yet known, but I believe that until the end of [...]
Kosovo expects by the end of December to accept the result of samples sent abroad, to see if they are positive for the new version of the coronary, Omitron.
“And we have not accepted the results of the last samples. The exact date is not yet known, but I believe that by the end of the month until 28-29 December, I believe they return (the results)”, the Free Europe Radio, Era Piraeus, spokesperson of the National Institute of Public Health of Kosovo (IKSHPK).
She said that even during December 20th new samples will be sent to Germany for analysis.
Kosovo sent 72 samples to a laboratory in Germany in early December through a European Centre for Disease Control and Prevention programme (ECDC) to see if the Omitron variant is present in them.
IK The KPS has also sent samples to Germany to identify the presence of the Delta and Delta Plus variant, as Kosovo has no capacity to do so.
Currently, the epidemiological situation in Kosovo is rated calm and there are a little over 300 active cases of coronary activity in the country.
Unlike Kosovo, the countries of the region and Europe are facing increased cases of COVID-19, due to the Omitron variant, which is believed to be transmitted faster than preliminary variants, including the Delta version.
Because of Omitron, many European states have restored restrictive measures, and the Netherlands has become the first state to declare nationwide isolation by mid-January next year.
The Omitron version was first identified in South Africa in November. Since then, dozens of countries have reported cases of this option.
The World Health Organization has classified this option as “disturbing” because of its multiple mutations.











